Day M J, Karkare U, Schultz R D, Squires R, Tsujimoto H
School of Veterinary Sciences, University of Bristol, Langford, BS40 5DU.
J Small Anim Pract. 2015 Feb;56(2):77-95. doi: 10.1111/jsap.12272. Epub 2014 Oct 7.
In 2012 and 2013, the World Small Animal Veterinary Association (WSAVA) Vaccination Guidelines Group (VGG) undertook fact-finding visits to several Asian countries, with a view to developing advice for small companion animal practitioners in Asia related to the administration of vaccines to dogs and cats. The VGG met with numerous first opinion practitioners, small animal association leaders, academic veterinarians, government regulators and industry representatives and gathered further information from a survey of almost 700 veterinarians in India, China, Japan and Thailand. Although there were substantial differences in the nature and magnitude of the challenges faced by veterinarians in each country, and also differences in the resources available to meet those challenges, overall, the VGG identified insufficient undergraduate and postgraduate training in small companion animal microbiology, immunology and vaccinology. In most of the countries, there has been little academic research into small animal infectious diseases. This, coupled with insufficient laboratory diagnostic support, has limited the growth of knowledge concerning the prevalence and circulating strains of key infectious agents in most of the countries visited. Asian practitioners continue to recognise clinical infections that are now considered uncommon or rare in western countries. In particular, canine rabies virus infection poses a continuing threat to animal and human health in this region. Both nationally manufactured and international dog and cat vaccines are variably available in the Asian countries, but the product ranges are small and dominated by multi-component vaccines with a licensed duration of immunity (DOI) of only 1 year, or no description of DOI. Asian practitioners are largely unaware of current global trends in small animal vaccinology or of the WSAVA vaccination guidelines. Consequently, most practitioners continue to deliver annual revaccination with both core and non-core vaccines to adult animals, with little understanding that "herd immunity" is more important than frequent revaccination of individual animals within the population. In this paper, the VGG presents the findings of this project and makes key recommendations for the Asian countries. The VGG recommends that (1) Asian veterinary schools review and increase as needed the amount of instruction in small animal vaccinology within their undergraduate curriculum and increase the availability of pertinent postgraduate education for practitioners; (2) national small animal veterinary associations, industry veterinarians and academic experts work together to improve the scientific evidence base concerning small animal infectious diseases and vaccination in their countries; (3) national small animal veterinary associations take leadership in providing advice to practitioners based on improved local knowledge and global vaccination guidelines; (4) licensing authorities use this enhanced evidence base to inform and support the registration of improved vaccine product ranges for use in their countries, ideally with DOI for core vaccines similar or equal to those of equivalent products available in western countries (i.e. 3 or 4 years). The VGG also endorses the efforts made by Asian governments, non-governmental organisations and veterinary practitioners in working towards the goal of global elimination of canine rabies virus infection. In this paper, the VGG offers both a current pragmatic and future aspirational approach to small animal vaccination in Asia. As part of this project, the VGG delivered continuing education to over 800 Asian practitioners at seven events in four countries. Accompanying this document is a list of 80 frequently asked questions (with answers) that arose during these discussions. The VGG believes that this information will be of particular value to Asian veterinarians as they move towards implementing global trends in small companion animal vaccinology.
2012年和2013年,世界小动物兽医协会(WSAVA)疫苗接种指南小组(VGG)对几个亚洲国家进行了实情调研访问,旨在为亚洲小型伴侣动物从业者提供有关犬猫疫苗接种的建议。VGG会见了众多初诊从业者、小动物协会领导、学术兽医、政府监管人员和行业代表,并通过对印度、中国、日本和泰国近700名兽医的调查收集了更多信息。尽管每个国家兽医面临的挑战在性质和程度上存在很大差异,应对这些挑战的可用资源也有所不同,但总体而言,VGG发现小型伴侣动物微生物学、免疫学和疫苗学方面的本科和研究生培训不足。在大多数国家,针对小动物传染病的学术研究很少。这一点,再加上实验室诊断支持不足,限制了在所访问的大多数国家中有关主要传染病原体的流行情况和传播菌株的知识增长。亚洲从业者仍能识别出一些在西方国家现已被视为不常见或罕见的临床感染。特别是,犬狂犬病病毒感染对该地区的动物和人类健康持续构成威胁。亚洲国家既有国产的也有国际的犬猫疫苗,但产品种类有限,且多为多组分疫苗,其免疫许可期限(DOI)仅为1年,或未注明DOI。亚洲从业者大多不了解当前小动物疫苗学的全球趋势或WSAVA疫苗接种指南。因此,大多数从业者继续对成年动物每年进行核心疫苗和非核心疫苗的再接种,几乎不了解“群体免疫”比在群体内频繁对个体动物进行再接种更为重要。在本文中,VGG介绍了该项目的研究结果,并为亚洲国家提出了关键建议。VGG建议:(1)亚洲兽医学校审查并根据需要增加本科课程中小动物疫苗学的教学量,并为从业者提供更多相关的研究生教育机会;(2)国家小动物兽医协会、行业兽医和学术专家共同努力,改善本国有关小动物传染病和疫苗接种的科学证据基础;(3)国家小动物兽医协会发挥领导作用,根据改进后的本地知识和全球疫苗接种指南为从业者提供建议;(4)许可当局利用这一强化的证据基础,为在本国使用的改进型疫苗产品系列的注册提供信息并提供支持,理想情况下核心疫苗的DOI应与西方国家同类产品相似或相同(即3年或四年)。VGG还认可亚洲各国政府、非政府组织和兽医从业者为实现全球消除犬狂犬病病毒感染目标所做的努力。在本文中,VGG为亚洲的小动物疫苗接种提供了当前务实和未来理想的方法。作为该项目的一部分,VGG在四个国家的七场活动中为800多名亚洲从业者提供了继续教育。随本文附上了在这些讨论中出现的80个常见问题(及答案)清单。VGG认为,这些信息对于亚洲兽医在迈向实施小型伴侣动物疫苗学全球趋势的过程中将具有特别价值。